Cancer Biomarkers and Oncoviruses
- 1st Edition - December 1, 2025
- Imprint: Academic Press
- Editor: Moulay Mustapha Ennaji
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 0 2 2 5 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 0 2 2 6 - 8
Cancer Biomarkers and Oncoviruses examines the extensive clinical applications of biomarkers in cancer research, with a particular focus on oncoviruses. The book explores key to… Read more
Purchase options
Cancer Biomarkers and Oncoviruses examines the extensive clinical applications of biomarkers in cancer research, with a particular focus on oncoviruses. The book explores key topics such as cancer risk assessment, screening, and early detection. It further covers accurate diagnosis, patient prognosis, prediction of response to therapy, and cancer surveillance and monitoring. In 47 detailed chapters, Cancer Biomarkers and Oncoviruses presents the molecular biology and pathogenesis of viral oncology, the mechanisms of viral oncogenesis in humans, signaling pathways, and therapeutic options such as vaccines. It also discusses the future of cancer therapy involving oncoviruses.
The present book also covers critical analyses of cost savings in healthcare, respiratory biomarkers in viral infections, and lessons learned from the COVID-19 pandemic, focusing on pandemic preparedness, early detection, surveillance, and response strategies. These discussions aim to provide valuable insights into how lessons from the pandemic can be applied to improve healthcare systems and response strategies for both viral infections and cancer, helping inform future health management practices.
This book is an invaluable resource for health professionals, scientists, researchers, health practitioners, students, and anyone seeking to deepen their understanding in the field of cancer and virology. It offers valuable state-of-the-art insights, incorporating the latest research and cutting-edge developments in the field.
The present book also covers critical analyses of cost savings in healthcare, respiratory biomarkers in viral infections, and lessons learned from the COVID-19 pandemic, focusing on pandemic preparedness, early detection, surveillance, and response strategies. These discussions aim to provide valuable insights into how lessons from the pandemic can be applied to improve healthcare systems and response strategies for both viral infections and cancer, helping inform future health management practices.
This book is an invaluable resource for health professionals, scientists, researchers, health practitioners, students, and anyone seeking to deepen their understanding in the field of cancer and virology. It offers valuable state-of-the-art insights, incorporating the latest research and cutting-edge developments in the field.
- Provides current, systematic scientific information on oncoviruses, including the molecular characteristics of cancers associated with these viruses, along with recent diagnostic and treatment strategies, and future perspectives in the field
- Addresses key topics in tumor science by offering a comprehensive overview of cancers, covering diagnosis, cellular mechanisms, and therapeutic approaches
- Incorporates critical analyses and lessons learned from the COVID-19 pandemic, focusing on pandemic preparedness, early detection, surveillance, and response strategies, providing insights that can be applied to cancer research and healthcare management
- Offers up-to-date and comprehensive information to support informed decision-making regarding cancer diagnosis, treatment, and research, while also helping to shape future healthcare practices
Researchers working across the biosciences in the fields of oncology, molecular biology and virology
1. Viral Oncology: Molecular Biology and Pathogenesis
2. History, discovery and Taxonomy of viruses-tumor complications, Structure and Genom
3. Oncoviruses Associated Tumors
4. Oncoviruses Oncogenic Factors
5. Therapeutic Options Molecular mechanisms of viral oncogenesis in humans
6. Targeting tumour suppressor pathways
7. PI3K–AKT–mTOR signalling.
8. MAPK signalling.
9. WNT/β-catenin signalling.
10. Mechanism of virus actions
11. Future of Cancer Therapy of onco viruses
12. Recent advances in oncoviruses prevention and curative treatments
13. Vaccine strategies
14. Antiviral activities of oncoviruses
15. Modelling of oncovirus knowledge
16. Bioinformatics serving oncoviral studies
17. Cell signalling and oncoviruses
2. History, discovery and Taxonomy of viruses-tumor complications, Structure and Genom
3. Oncoviruses Associated Tumors
4. Oncoviruses Oncogenic Factors
5. Therapeutic Options Molecular mechanisms of viral oncogenesis in humans
6. Targeting tumour suppressor pathways
7. PI3K–AKT–mTOR signalling.
8. MAPK signalling.
9. WNT/β-catenin signalling.
10. Mechanism of virus actions
11. Future of Cancer Therapy of onco viruses
12. Recent advances in oncoviruses prevention and curative treatments
13. Vaccine strategies
14. Antiviral activities of oncoviruses
15. Modelling of oncovirus knowledge
16. Bioinformatics serving oncoviral studies
17. Cell signalling and oncoviruses
- Edition: 1
- Published: December 1, 2025
- Imprint: Academic Press
- Language: English
ME
Moulay Mustapha Ennaji
Dr. Moulay Mustapha Ennaji, Professor in Virology and Oncology at the University of Casablanca and Director of the Quality and Medical Biotechnologies Team at Laboratory of Virology Microbiology, Hassan II University Mohammedia of Casablanca, Morocco He is currently a Professor in Virology and Oncology at the University of Casablanca, and since 2010, he has been the Director of the Quality and Medical Biotechnologies Team at the Laboratory of Virology Microbiology, Quality, Biotechnologies. He received a MSc in 1986 and a PhD in virology in 1993 from Armand Frappier Institute, University of Quebec (Canada). He has published dozens of journals articles and is an editorial board member of the journal, Infectious Agents and Cancer. Throughout his career, Dr. Ennaji has been rewarded several awards. At present, he is the vice president of the three Moroccan societies of Biosafety, Cancer, and Microbiology.
Affiliations and expertise
Professor, Virology and Oncology, University of Casablanca, Morocco; Director, Quality and Medical Biotechnologies Team, Laboratory of Virology Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity; Faculty, Sciences and Techniques, Hassan II University Mohammedia of Casablanca, Morocco